Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population

ObjectiveLow muscle mass often indicates poor health, but the relation with cardiovascular disease (CVD) is unknown. Skeletal muscles are responsible for approximately 75% of insulin stimulated whole body glucose disposal and therefore insulin resistance could underlie the relation between muscle mass and CVD. We aimed to determine whether muscle mass, as reflected by 24 h urinary creatinine excretion, is associated with CVD and whether this depends on insulin resistance.MethodsThe study was performed in the prospective, community-based, observational cohort of the PREVEND study in Groningen, the Netherlands. 24 h creatinine excretion was assessed in 4044 women and 4048 men. Outcome events were incidence of major adverse cardiovascular events (MACE) and all-cause mortality, with a follow-up of 7.5 [7.3–7.9] years. Insulin resistance was estimated using fasting insulin and HOMA.ResultsIn women every doubling of creatinine excretion was associated with an approximate 60% decrease in risk for MACE (hazard ratio (HR) 0.41 [95%CI 0.26–0.64], P < 0.001) and 50% decrease in risk for all-cause mortality (HR: 0.52 [0.31–0.90], P = 0.02) independent of age, smoking, CVD history, race, fasting insulin concentrations and components of the metabolic syndrome. In men every doubling of creatinine excretion was borderline associated with an approximately 25% decrease in risk for MACE (HR: 0.74 [0.53–1.03], P = 0.07) and independently associated with a 55% decreased risk for all-cause mortality (HR: 0.45 [0.32–0.62], P < 0.001).ConclusionsLow creatinine excretion, as indirect measure of low muscle mass, is associated with MACE and all-cause mortality in the general population, independent of insulin resistance. Perhaps protein–calorie malnutrition or physical activity could underlie the association between muscle mass and CVD.